Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Cash Flows From Operating Activities | |
| Net Income | -5,971 |
| Depreciation Amortization | 644 |
| Accounts receivable | 977 |
| Accounts payable and accrued liabilities | 286 |
| Other Working Capital | 2,071 |
| Other Operating Activity | -960 |
| Operating Cash Flow | $-2,953 |
| Cash Flows From Investing Activities | |
| PPE Investments | -10 |
| Investing Cash Flow | $-10 |
| Cash Flows From Financing Activities | |
| Debt Issued | 5,372 |
| Debt Repayment | -4 |
| Common Stock Issued | 45 |
| Other Financing Activity | -93 |
| Financing Cash Flow | $5,320 |
| Exchange Rate Effect | -4 |
| Beginning Cash Position | 2,890 |
| End Cash Position | 5,243 |
| Net Cash Flow | $2,353 |
| Free Cash Flow | |
| Operating Cash Flow | -2,953 |
| Capital Expenditure | -10 |
| Free Cash Flow | -2,963 |